{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T19:42:20Z","timestamp":1648842140794},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1997,2,1]],"date-time":"1997-02-01T00:00:00Z","timestamp":854755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"vor","delay-in-days":8364,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1997,2]]},"DOI":"10.1023\/a:1008293415079","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T13:47:34Z","timestamp":1040564854000},"page":"195-197","source":"Crossref","is-referenced-by-count":4,"title":["Ifosfamide and paclitaxel salvage chemotherapy for advanced epithelial ovarian cancer"],"prefix":"10.1016","volume":"8","author":[{"given":"M.A.","family":"Dimopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Papadimitriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gennatas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Akrivos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Vlahos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Voulgaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Diacomanolis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Athanassiades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Mihalas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008293415079_bb0005","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.1994.12.12.2654","article-title":"European\u2013Canadian randomized trial of paclitaxel in relapsed ovarian cancer: High-dose versus low-dose and long versus short infusion","volume":"12","author":"Eisenhauer","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008293415079_bb0010","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1200\/JCO.1994.12.9.1748","article-title":"Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: A Gynecologic Oncology Group Study","volume":"12","author":"Thigpen","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008293415079_bb0015","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1200\/JCO.1989.7.11.1672","article-title":"Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma: A Gynecologic Oncology Group study","volume":"7","author":"Sutton","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008293415079_bb0020","first-page":"243","article-title":"Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer","volume":"10","author":"Markman","year":"1992","journal-title":"Activity in platinum-resistant disease. J Clin Oncol"},{"key":"10.1023\/A:1008293415079_bb0025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/gyno.1995.1012","article-title":"A phase 2 trial of ifosfamide\/mesna as salvage therapy in patients with ovarian cancer refractory to or relapsing after prior platinum-containing chemotherapy","volume":"56","author":"Sorensen","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1023\/A:1008293415079_bb0030","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/oxfordjournals.annonc.a010612","article-title":"Salvage therapy with ifosfamide and mitoxantrone in advanced ovarian cancer","volume":"7","author":"Marzola","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008293415079_bb0035","first-page":"513","article-title":"Responses to \u2018salvage\u2019 chemotherapy in ovarian cancer","volume":"10","author":"Markman","year":"1992","journal-title":"A critical need for precise definitions of the treated population. J Clin Oncol"},{"key":"10.1023\/A:1008293415079_bb0040","first-page":"301","article-title":"Paclitaxel and ifosfamide in heavily pretreated patients with advanced ovarian cancer","volume":"15","author":"Pucci","year":"1996","journal-title":"Proc ASCO"},{"key":"10.1023\/A:1008293415079_bb0045","first-page":"295","article-title":"Paclitaxel and ifosfamide in pretreated patients with advanced ovarian carcinoma","volume":"15","author":"Klaassen","year":"1996","journal-title":"Proc ASCO"},{"key":"10.1023\/A:1008293415079_bb0050","first-page":"279","article-title":"Paclitaxel vs","volume":"15","author":"Colombo","year":"1996","journal-title":"CAP (cyclophosphamide, adriamycin, cisplatin) in recurrent platinum sensitive ovarian cancer: A randomized phase II stady. Proc ASCO"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419481337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419481337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/8\/2\/195\/19480658\/8-2-195.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T17:02:36Z","timestamp":1582218156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419481337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1997,2]]}},"alternative-id":["S0923753419481337"],"URL":"https:\/\/doi.org\/10.1023\/a:1008293415079","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1997,2]]}}}